A randomized clinical trial in subjects with dry mouth evaluating subjective perceptions of an experimental oral gel, an oral rinse and a mouth spray compared to water.
OBJECTIVE
This multicenter, randomized, parallel group study analyzed the effectiveness of an experimental oral gel, a commercially available oral rinse and a commercially available mouth spray versus water alone at relieving self-reported symptoms of dry mouth over a 28-day home use treatment period. The effects of the study treatments on dry mouth-related quality of life (QoL) were also investigated.


METHODS
Eligible subjects were stratified by dry mouth severity (mild, moderate or severe) and randomized to receive one of the study treatments. Prior to first use they completed a questionnaire designed to assess their baseline dry mouth-related QoL. Following first use and on Day 8 (2 hours post-treatment only) and Day 29, subjects completed the modified Product Performance and Attributes Questionnaire (PPAQ) I at 0.5, 1, 2 and 4 hours post-treatment. Subjects further assessed treatment performance using the PPAQ II questionnaire on Days 8 and 29 and the dry mouth-related QoL questionnaire on Day 29.


RESULTS
In 396 randomized subjects almost all comparisons of responses to PPAQ I, including those for the primary endpoint (response to PPAQ I Question 1 'Relieving the discomfort of dry mouth' after 2 hours on Day 29), were statistically significant in favor of active treatment groups versus water (P < 0.05). All comparisons of responses to PPAQ II on Days 8 and 29 were statistically significant in favor of active treatments versus water (P < 0.05). Moreover, nearly all comparisons for dry mouth-related QoL scores on Day 29 were statistically significant in favor of the active treatments versus water. All the dry mouth management strategies in this trial were well tolerated.
Anto
A
Jose
Muhammad
M
Siddiqi
Matthew
M
Cronin
Thomas S
TS
DiLauro
Mary Lynn
ML
Bosma
D000328:Adult; D000336:Aerosols; D000368:Aged; D000369:Aged, 80 and over; D001294:Attitude to Health; D004338:Drug Combinations; D005260:Female; D005500:Follow-Up Studies; D005782:Gels; D005949:Glucose Oxidase / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007784:Lactoperoxidase / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D054327:Lubricants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009067:Mouthwashes / Q000627:therapeutic use; D009113:Muramidase / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011788:Quality of Life; D012649:Self Concept; D057566:Self Report; D016896:Treatment Outcome; D014867:Water; D014987:Xerostomia / Q000145:classification / Q000517:prevention & control* / Q000523:psychology
D000336:Aerosols; C111669:Biotene; D004338:Drug Combinations; D005782:Gels; D054327:Lubricants; D009067:Mouthwashes; D014867:Water; D005949:Glucose Oxidase; D007784:Lactoperoxidase; D009113:Muramidase